Published in Cell Oncol (Dordr) on October 11, 2012
Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas. Head Neck Pathol (2013) 0.91
Intestinal type of lung adenocarcinoma in younger adults. Case Rep Pulmonol (2014) 0.89
High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma. Cancer Res (2015) 0.83
Metastatic behaviour of sinonasal adenocarcinomas of the intestinal type (ITAC). Eur Arch Otorhinolaryngol (2015) 0.81
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol (2010) 2.42
Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol (2006) 1.96
Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J (2007) 1.74
Matrix metalloproteinases and tumor progression. Adv Exp Med Biol (2003) 1.61
[Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck]. Med Clin (Barc) (2007) 1.41
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res (2007) 1.37
Elective and therapeutic selective neck dissection. Oral Oncol (2005) 1.26
Squamous cell carcinoma of the external auditory canal. Skull Base (2008) 1.18
Neck dissection: then and now. Auris Nasus Larynx (2006) 1.14
Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias. Clin Cancer Res (2004) 1.14
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck (2011) 1.13
Benign lesions in mucosa adjacent to intestinal-type sinonasal adenocarcinoma. Patholog Res Int (2011) 1.11
Grisel's syndrome in head and neck practice. Oral Oncol (2005) 1.11
Platinum-catalyzed intramolecular [4C+3C] cycloaddition between dienes and allenes. Angew Chem Int Ed Engl (2008) 1.11
Gold-catalyzed [4C+2C] cycloadditions of allenedienes, including an enantioselective version with new phosphoramidite-based catalysts: mechanistic aspects of the divergence between [4C+3C] and [4C+2C] pathways. J Am Chem Soc (2009) 1.09
Retropharyngeal lymph node metastases in head and neck malignancies. Head Neck (2010) 1.09
Genomic profiling of sinonasal squamous cell carcinoma. Head Neck (2011) 1.08
Head and neck paragangliomas: clinical and molecular genetic classification. Clinics (Sao Paulo) (2012) 1.07
[Paranasal sinuses mucoceles. Our experience in 72 patients]. Acta Otorrinolaringol Esp (2009) 1.07
Comment on: Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): a model for sustainable development in Pediatric Oncology. Pediatr Blood Cancer (2014) 1.07
Complications of free flap transfers for head and neck reconstruction following cancer resection. Oral Oncol (2004) 1.06
Proposal for a rational classification of neck dissections. Head Neck (2010) 1.04
Craniopharyngioma: a pathologic, clinical, and surgical review. Head Neck (2011) 1.04
Modern reconstruction techniques for oral and pharyngeal defects after tumor resection. Eur Arch Otorhinolaryngol (2007) 1.04
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer. Breast Cancer Res Treat (2011) 1.03
Mesenchymal chondrosarcoma of the head and neck. Oral Oncol (2007) 1.02
Is there an epidemiological link between human papillomavirus DNA and basaloid squamous cell carcinoma of the pharynx? Oral Oncol (2006) 1.01
Genetic and clinical aspects of wood dust related intestinal-type sinonasal adenocarcinoma: a review. Eur Arch Otorhinolaryngol (2008) 1.01
Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009). Int J Cancer (2013) 1.01
Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2012) 1.00
Primary treatment of the anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol (2006) 0.99
Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy. Head Neck (2011) 0.99
High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications. Hum Genet (2006) 0.98
An iterative catalytic route to enantiopure deoxypropionate subunits: asymmetric conjugate addition of grignard reagents to alpha,beta-unsaturated thioesters. J Am Chem Soc (2005) 0.98
[Unusual clinical presentations of vestibular schwannomas]. Acta Otorrinolaringol Esp (2008) 0.97
Evolution of the management of laryngeal cancer. Oral Oncol (2006) 0.96
Gold-catalyzed [4C+3C] intramolecular cycloaddition of allenedienes: synthetic potential and mechanistic implications. Chemistry (2009) 0.96
Functional outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck (2004) 0.96
Merkel cell carcinoma of the head and neck. Head Neck (2011) 0.96
Management of the N0 neck--reference or preference. Oral Oncol (2005) 0.95
Jaw tissues segmentation in dental 3D CT images using fuzzy-connectedness and morphological processing. Comput Methods Programs Biomed (2012) 0.95
Physical and mental component summaries score of the SF-36 in coronary patients. Qual Life Res (2005) 0.95
When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol (2010) 0.94
Genetics of hereditary head and neck paragangliomas. Head Neck (2013) 0.94
Deletions of N33, STK11 and TP53 are involved in the development of lymph node metastasis in larynx and pharynx carcinomas. Cell Oncol (2007) 0.92
KRAS and BRAF mutations in sinonasal cancer. Oral Oncol (2012) 0.92
Future of the TNM classification and staging system in head and neck cancer. Head Neck (2010) 0.92
Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications. J Mol Med (Berl) (2012) 0.91
Neuromonitoring of the laryngeal nerves in thyroid surgery: a critical appraisal of the literature. Eur Arch Otorhinolaryngol (2013) 0.91
New molecular diagnostic methods in head and neck cancer. Head Neck (2005) 0.90
Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma. BMC Cancer (2011) 0.90
Axially chiral triazoloisoquinolin-3-ylidene ligands in gold(I)-catalyzed asymmetric intermolecular (4 + 2) cycloadditions of allenamides and dienes. J Am Chem Soc (2012) 0.90
Nitric oxide regulates matrix metalloprotease-13 expression and activity in endothelium. Kidney Int (2002) 0.90
Neck treatment and shoulder morbidity: still a challenge. Head Neck (2010) 0.90
Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol (2010) 0.89
Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses. J Biol Chem (2013) 0.89
Subtemporal-preauricular approach in the management of infratemporal and nasopharyngeal tumours. J Otolaryngol (2006) 0.89
Preliminary multi-institutional prospective pathologic and molecular studies support preservation of sublevel IIB and level IV for laryngeal squamous carcinoma with clinically negative neck. Eur Arch Otorhinolaryngol (2006) 0.89
Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type. Cell Oncol (Dordr) (2011) 0.88
Expression patterns of matrix metalloproteinases and vascular endothelial growth factor during epiphyseal ossification. J Bone Miner Res (2005) 0.88
Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain). BMC Cancer (2013) 0.88
Comparative genomic hybridization in primary sinonasal adenocarcinomas. Cancer (2004) 0.88
P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question. Cancer (2007) 0.88
Gold(I)-catalyzed cascade cycloadditions between allenamides and carbonyl-tethered alkenes: an enantioselective approach to oxa-bridged medium-sized carbocycles. Angew Chem Int Ed Engl (2013) 0.87
Transoral laser surgery for supraglottic cancer. Head Neck (2008) 0.87
Clival chordomas: A pathological, surgical, and radiotherapeutic review. Head Neck (2013) 0.86
Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck (2008) 0.86
Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy. Cancer Prev Res (Phila) (2011) 0.86
Desmoid tumors of the head and neck: a therapeutic challenge. Head Neck (2014) 0.86
Treatment considerations for head and neck cancer in the elderly. J Laryngol Otol (2005) 0.86
Screening for familial paragangliomas. Oral Oncol (2007) 0.86
Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas. J Clin Endocrinol Metab (2012) 0.86
Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas. Mod Pathol (2012) 0.86
Idiopathic midline destructive disease: fact or fiction. Oral Oncol (2005) 0.86
Elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: is dissection of sublevel IIB necessary? Oral Oncol (2007) 0.86
Wood dust-related mutational profile of TP53 in intestinal-type sinonasal adenocarcinoma. Hum Pathol (2012) 0.85
Annexin A1 expression in nasopharyngeal carcinoma correlates with squamous differentiation. Am J Rhinol (2005) 0.85
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck (2006) 0.85
Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation. Histopathology (2012) 0.85
Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directions. Eur Arch Otorhinolaryngol (2011) 0.85
Causes of death of patients with laryngeal cancer. Eur Arch Otorhinolaryngol (2013) 0.85
Acquired genomic aberrations associated with methotrexate resistance vary with background genomic instability. Genes Chromosomes Cancer (2008) 0.84